Featured News Release
4/27/17 4:30 pm EDT
ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (NYSE: IVC) today reported it has completed the
final two milestones required to initiate the United States Food and
Drug Administration's (FDA) re-inspection of the company's Corporate and
Taylor Street facilities, which have been impacted by a consent decree
with FDA since December 2012. The re-inspection is an important step
before the company may resume full operations at the impacted facilities.
In order tomore...
Business Wire NewsHQ℠